Substance P, Obesity, and Gut Inflammation

Current Opinion in Endocrinology, Diabetes and Obesity - United States
doi 10.1097/med.0b013e328321306c
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Antibiotics, Gut Microbiome, and Obesity

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Obesity and Metabolic Inflammation

Drug Discovery Today: Disease Mechanisms
2013English

Blockade of Cardiac Inflammation in Mg2+ Deficiency by Substance P Receptor Inhibition

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1994English

Inflammation, Oxidative Stress, and Obesity

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2011English

Obesity and Cancer: A Gut Microbial Connection

Cancer Research
Cancer ResearchOncology
2014English

In Vitroprostanoid Release From Spinal Cord Following Peripheral Inflammation: Effects of Substance P, NMDA and Capsaicin

British Journal of Pharmacology
Pharmacology
1999English

Pregestational Overweight and Obesity Are Associated With Differences in Gut Microbiota Composition and Systemic Inflammation in the Third Trimester

PLoS ONE
Multidisciplinary
2018English

Nutritional Modulation of Gut Inflammation

Proceedings of the Nutrition Society
MedicineNutritionDietetics
1998English

Dietary Cellulose Prevents Gut Inflammation by Modulating Lipid Metabolism and Gut Microbiota

Gut Microbes
Infectious DiseasesMicrobiologyGastroenterology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy